TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Illinois Investigators

Thomas Gajewski, MD, PhD

University of Chicago Hospital


Chicago, Illinois - 60637 (773-834-9120)

University of Chicago


Chicago, Illinois - 60637
  • CLINICAL TRIALS 3
  • CONDITIONS1
  • INTERVENTIONS4
  • SINCE2006
Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma

March 2008 - December 2011
Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal Acral or Chronically Sun Damaged Melanoma

January 2009 - January 2012
Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma

July 2006 - July 2010
Melanoma

Nilotinib

Interferon Alpha

Kw2871

Imatinib

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo